Signals, Powered By EquityPandit
Sun Pharma the largest drug maker of the country, has posted a 13.59 percent decline in its consolidated net profit at Rs 1,223.71 crore for the quarter ended March.
The company had posted a profit of Rs 1,416.13 crore in the corresponding quarter of previous year.
The net sales stood at Rs 6,825.16 crore for the quarter as against Rs 7,415.98 crore of same period of previous year.
The EPS for the quarter fell to Rs 5.2 from 6.1 in the December quarter and Rs 5.9 in the March quarter of 2016.
The company’s board has recommended dividend of Rs 3.5 per share.
